Isoray Stock Forecast, Price & News

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Isoray in the last year. There are currently 1 hold rating and 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Isoray.

Wall Street analysts have given Isoray a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Isoray wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Isoray is scheduled to release its next quarterly earnings announcement on Tuesday, February 9th 2021.
View our earnings forecast for Isoray.

Isoray, Inc. (NYSEAMERICAN:ISR) announced its quarterly earnings results on Tuesday, November, 10th. The healthcare company reported ($0.01) earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of ($0.01).
View Isoray's earnings history.

Isoray updated its first quarter 2021 After-Hours earnings guidance on Thursday, September, 17th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $2.3-2.5 million, compared to the consensus revenue estimate of $3.1 million.

3 brokerages have issued 1 year price targets for Isoray's stock. Their forecasts range from $1.25 to $1.75. On average, they expect Isoray's share price to reach $1.50 in the next year. This suggests a possible upside of 313.3% from the stock's current price.
View analysts' price targets for Isoray.

Isoray saw a drop in short interest in the month of October. As of October 30th, there was short interest totaling 962,400 shares, a drop of 25.4% from the October 15th total of 1,290,000 shares. Based on an average trading volume of 570,200 shares, the days-to-cover ratio is presently 1.7 days.
View Isoray's Short Interest.

Some companies that are related to Isoray include Milestone Scientific (MLSS), Daxor (DXR), Daxor (DXR), TransEnterix (TRXC), TSO3 (TOS), Akers Biosciences (AKR), Relevium Technologies Inc. (RLV.V) (RLV), Vigil Health Solutions Inc. (VGL.V) (VGL), Ambu A/S (AMBBY), American Medical Technologies (ADLI), Ansell (ANSLY), Ansell (ANSLF), Ansell Limited (ANN.AX) (ANN), BATM Advanced Communications (BTAVF) and Carl Zeiss Meditec (CZMWY).
View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Isoray investors own include Brainstorm Cell Therapeutics (BCLI), OPKO Health (OPK), Bausch Health Companies (BHC), Anavex Life Sciences (AVXL), TherapeuticsMD (TXMD), Catalyst Pharmaceuticals (CPRX), MannKind (MNKD), CTI BioPharma (CTIC), Idera Pharmaceuticals (IDRA) and Palatin Technologies (PTN).

Isoray trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "ISR."

Isoray's stock is owned by a variety of retail and institutional investors. Top institutional investors include Squarepoint Ops LLC (0.10%) and Avantax Advisory Services Inc. (0.07%). Company insiders that own Isoray stock include Jonathan Robert Hunt, Lori A Woods, Mark John Austin, Michael Krachon, Philip J Vitale and William Cavanagh.
View institutional ownership trends for Isoray.

ISR stock was acquired by a variety of institutional investors in the last quarter, including Squarepoint Ops LLC, and Avantax Advisory Services Inc.. Company insiders that have bought Isoray stock in the last two years include Jonathan Robert Hunt, Lori A Woods, Mark John Austin, Michael Krachon, Philip J Vitale, and William Cavanagh.
View insider buying and selling activity for Isoray.

Shares of ISR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of ISR stock can currently be purchased for approximately $0.36.

Isoray has a market capitalization of $31.65 million. Isoray employs 53 workers across the globe.

The official website for Isoray is isoray.com.

Isoray's mailing address is 350 Hills St Ste 106, RICHLAND, WA 99354-5511, United States. The healthcare company can be reached via phone at (509) 375-1202.